Section of Nephrology, Yale University School of Medicine, New Haven, CT, 06520, USA.
Biostatistics, Yale University School of Public Health, New Haven, CT, 06511, USA.
BMC Nephrol. 2019 Feb 14;20(1):55. doi: 10.1186/s12882-019-1241-1.
Autosomal dominant polycystic kidney disease (ADPKD) affects all races. Whether the progression of ADPKD varies by race remains unclear.
In this retrospective cohort study from 2004 to 2013 non-Hispanic blacks and non-Hispanic whites of all ages classified in the US Renal Data System (USRDS) with incident ESRD from ADPKD (n = 23,647), hypertension/large vessel disease (n = 296,352), or diabetes mellitus (n = 451,760) were stratified into five-year age categories ranging from < 40 to > 75 (e.g., < 40, 40-44, 45-49, …, 75+). The Cochran-Mantel-Haenszel test was used to determine the association of race and incidence of ESRD from ADPKD, diabetes, or hypertension. The difference in the proportions of ESRD in non-Hispanic black and non-Hispanic white patients at each age categorical bin was compared by two-sample proportion test. The age of ESRD onset between non-Hispanic black and non-Hispanic white patients at each year was compared using two-sample t-test with unequal variance.
1.068% of non-Hispanic blacks and 2.778% of non-Hispanic whites had ESRD attributed to ADPKD. Non-Hispanic blacks were less likely than non-Hispanic whites to have ESRD attributed to ADPKD (odds ratio (OR) (95% CI) = 0.38 (0.36-0.39), p < 0.0001). Using US Census data as the denominator to adjust for population differences non-Hispanic blacks were still slightly under-represented (OR (95% CI) 0.94 (0.91-0.96), p = 0.004). However, non-Hispanic blacks with ADPKD had a younger age of ESRD (54.4 years ±13) than non-Hispanic whites (55.9 years ±12.8) (p < 0.0001). For those < 40 years old, more non-Hispanic blacks had incident ESRD from ADPKD than non-Hispanic whites (9.49% vs. 7.68%, difference (95% CI) = 1.81% (0.87-2.84%), p < 0.001) for the combined years examined.
As previously shown, we find the incidence of ESRD from ADPKD in non-Hispanic blacks is lower than in non-Hispanic whites. Among the younger ADPKD population (age < 40), however, more non-Hispanic blacks initiated dialysis than non-Hispanic whites. Non-Hispanic blacks with ADPKD initiated dialysis younger than non-Hispanic whites. A potential implication of these findings may be that black race should be considered an additional risk factor for progression in ADPKD.
常染色体显性多囊肾病(ADPKD)影响所有种族。ADPKD 的进展是否因种族而异尚不清楚。
本研究是一项 2004 年至 2013 年在美国肾脏数据系统(USRDS)中进行的回顾性队列研究,纳入了所有年龄段的非西班牙裔黑人和非西班牙裔白人,这些患者患有 ADPKD 引起的终末期肾病(ESRD)(n=23647)、高血压/大血管疾病(n=296352)或糖尿病(n=451760)。患者按年龄分为五个五年年龄段,范围从<40 岁到>75 岁(例如,<40 岁、40-44 岁、45-49 岁、……、75+岁)。采用 Cochran-Mantel-Haenszel 检验确定种族与 ADPKD、糖尿病或高血压引起的 ESRD 之间的关联。使用两样本比例检验比较每个年龄分类箱中非西班牙裔黑人和非西班牙裔白人患者中 ESRD 的比例差异。使用两样本 t 检验(方差不齐)比较非西班牙裔黑人和非西班牙裔白人患者每年 ESRD 发病年龄。
1.068%的非西班牙裔黑人和 2.778%的非西班牙裔白人患有 ADPKD 引起的 ESRD。与非西班牙裔白人相比,非西班牙裔黑人发生 ADPKD 引起的 ESRD 的可能性较低(比值比(OR)(95%CI)=0.38(0.36-0.39),p<0.0001)。使用美国人口普查数据作为分母来调整人口差异,非西班牙裔黑人的代表性仍然略低(OR(95%CI)0.94(0.91-0.96),p=0.004)。然而,非西班牙裔黑人的 ESRD 发病年龄较非西班牙裔白人年轻(54.4 岁±13 岁比 55.9 岁±12.8 岁)(p<0.0001)。对于<40 岁的患者,与非西班牙裔白人相比,非西班牙裔黑人发生 ADPKD 引起的 ESRD 的比例更高(9.49%比 7.68%,差异(95%CI)=1.81%(0.87-2.84%),p<0.001)。
与之前的研究结果一致,我们发现非西班牙裔黑人发生 ADPKD 引起的 ESRD 的发病率低于非西班牙裔白人。然而,在较年轻的 ADPKD 患者(年龄<40 岁)中,非西班牙裔黑人开始透析的比例高于非西班牙裔白人。与非西班牙裔白人相比,非西班牙裔黑人的 ADPKD 患者开始透析的年龄较小。这些发现可能意味着,黑人种族应被视为 ADPKD 进展的另一个危险因素。